Coagulation Factor IX for Hemophilia B Therapy

被引：27
|
作者：
Orlova, N. A. [1 ,2 ]
Kovnir, S. V. [1 ,2 ]
Vorobiev, I. I. [1 ,2 ]
Gabibov, A. G. [1 ]
机构：
[1] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[2] Minist Healthcare & Social Dev Russian Federat, Hematol Res Ctr, Moscow 125167, Russia
来源：
ACTA NATURAE | 2012年 / 4卷 / 02期
关键词：
coagulation factor IX; hemophilia B; heterologous protein expression systems; CLOTTING FACTOR-IX; RECOMBINANT FACTOR-IX; SUSTAINED PHENOTYPIC CORRECTION; PREVIOUSLY TREATED PATIENTS; MEDIATED GENE-TRANSFER; LONG-TERM CORRECTION; HUMAN PROTEIN-C; FACTOR-X; PHARMACOKINETIC PROPERTIES; STRUCTURAL-ANALYSIS;
D O I：
10.32607/20758251-2012-4-2-62-73
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Factor IX is a zymogen enzyme of the blood coagulation cascade. Inherited absence or deficit of the IX functional factor causes bleeding disorder hemophilia B, which requires constant protein replacement therapy. Reviewed herein are the current state in the manufacturing of FIX, improved variants of the recombinant protein for therapy, transgenic organisms for obtaining FIX, and the advances in the gene therapy of hemophilia B.
引用
收藏
页码：62 / 73
页数：12
相关论文
共 50 条
  • [1] BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B
    Windyga, Jerzy
    Abbuehl, Brigitt E.
    Hafeman, Andrea E.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 333 - 342
  • [2] Current factor IX replacement options for hemophilia B and the challenges ahead
    Franchini, Massimo
    Zaffanello, Marco
    Focosi, Daniele
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (06) : 729 - 736
  • [3] An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B
    Rallapalli, P. M.
    Kemball-Cook, G.
    Tuddenham, E. G.
    Gomez, K.
    Perkins, S. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (07) : 1329 - 1340
  • [4] Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment
    Franchini, Massimo
    Focosi, Daniele
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (09) : 939 - 944
  • [5] Nonacog beta pegol. Human blood coagulation factor IX, Treatment of hemophilia B
    Gajdosik, Z.
    DRUGS OF THE FUTURE, 2013, 38 (10) : 687 - 690
  • [6] Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery
    Preijers, T.
    Hazendonk, H. C. A. M.
    Liesner, R.
    Chowdary, P.
    Driessens, M. H. E.
    Hart, D.
    Keeling, D.
    Laros-van Gorkom, B. A. P.
    van der Meer, F. J. M.
    Meijer, K.
    Fijnvandraat, K.
    Leebeek, F. W. G.
    Collins, P. W.
    Cnossen, M. H.
    Mathot, R. A. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (11) : 2196 - 2207
  • [7] Hemophilia B (Factor IX Deficiency)
    Sidonio, Robert F., Jr.
    Malec, Lynn
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (06) : 1143 - 1155
  • [8] Factor IX assays in treated hemophilia B patients
    Pouplard, Claire
    Jeanpierre, Emmanuelle
    Lasne, Dominique
    Duchez, Veronique Le Cam
    Eschwege, Valerie
    Flaujac, Claire
    Galinat, Hubert
    Harzallah, Ines
    Proulle, Valerie
    Smahi, Motalib
    Sobas, Frederic
    Ternisien, Catherine
    Toulon, Pierre
    Voisin, Sophie
    Nougier, Christophe
    Gelas, Martine Alhenc
    Biron, Christine
    Blanc-Jouvan, Florence
    Bourgerette, Evelyne
    Bulabois, Benedicte
    Comio, Emilie
    Donnard, Magali
    Duchemin, Jerome
    Faure, Anne-Camille
    Grand, Francois
    Grunebaum, Lelia
    Guicheteau, Maryse
    Hezard, Nathalie
    Hurtaud, Marie-Francoise
    Gac, Fabienne Nedelec
    De Maistre, Emmanuel
    Marlu, Raphael
    Mourey, Guillaume
    Munier, Perrine
    Pineau-Vincent, Fabienne
    Raffenot, Didier
    Repesse, Yohan
    Ryman, Anne
    Sattler, Laurent
    Sauguet, Pauline
    Serre-Sapin, Anne-Francoise
    Stepanian, Alain
    Szymezak, Jean
    Tuffigo, Marie
    Voyer, Annelise
    ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (01) : 41 - 52
  • [9] Factor IX assays in treated hemophilia B patients
    Pouplard, Claire
    Jeanpierre, Emmanuelle
    Lasne, Dominique
    Duchez, Veronique Le Cam
    Eschwege, Valerie
    Flaujac, Claire
    Galinat, Hubert
    Harzallah, Ines
    Proulle, Valerie
    Smahi, Motalib
    Sobas, Frederic
    Ternisien, Catherine
    Toulon, Pierre
    Voisin, Sophie
    Nougier, Christophe
    HEMATOLOGIE, 2020, 26 (01): : 18 - 34
  • [10] GlycoPEGylated recombinant factor IX for hemophilia B in context
    Santagostino, Elena
    Mancuso, Maria Elisa
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2933 - 2943
12345